PURPOSE: To investigate whether short-term, intensive lipid therapy leads to changes in microvascular characteristics, as measured by using dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging. MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained for this HIPAA-compatible study. Subjects with established coronary artery disease or carotid artery stenosis of 15% or greater determined by using ultrasonography and with levels of apolipoprotein B of 120 mg/dL (1.2 g/L) or greater were enrolled in an ongoing study (clinical trial NCT00715273). All received intensive lipid therapy to achieve targeted high- and low-density lipoprotein cholesterol levels and underwent serial serum monitoring including high-sensitivity C-reactive protein (HsCRP) level measurements. Carotid artery MR imaging examinations including morphologic and DCE MR images were obtained at baseline and 1 year after treatment. In subjects with advanced lesions (>2 mm thick), MR image analysis was performed, including measurement of lipid-rich necrotic core size and kinetic modeling of DCE MR images to assess changes in the transfer constant (K(trans)). The differences in K(trans) between baseline and 1-year follow-up were compared by using the Wilcoxon signed rank test, and associations were assessed by using the Spearman rank correlation coefficient. RESULTS:Twenty-eight subjects with interpretable DCE MR imaging results at both baseline and 1-year follow-up were included. After 1 year of treatment, a significant reduction was found in mean K(trans) (0.085 min(-1) ± 0.037 [standard deviation] to 0.067 min(-1) ± 0.028, P = .02). Reduction in K(trans) was not significantly correlated with observed reductions in lipid-rich necrotic core size or reductions in HsCRP level. CONCLUSION: These findings suggest that DCE MR imaging may be a useful imaging method for the assessment of the therapeutic response of the vasa vasorum in patients with atherosclerotic plaque.
RCT Entities:
PURPOSE: To investigate whether short-term, intensive lipid therapy leads to changes in microvascular characteristics, as measured by using dynamic contrast material-enhanced (DCE) magnetic resonance (MR) imaging. MATERIALS AND METHODS: Institutional review board approval and informed consent were obtained for this HIPAA-compatible study. Subjects with established coronary artery disease or carotid artery stenosis of 15% or greater determined by using ultrasonography and with levels of apolipoprotein B of 120 mg/dL (1.2 g/L) or greater were enrolled in an ongoing study (clinical trial NCT00715273). All received intensive lipid therapy to achieve targeted high- and low-density lipoprotein cholesterol levels and underwent serial serum monitoring including high-sensitivity C-reactive protein (HsCRP) level measurements. Carotid artery MR imaging examinations including morphologic and DCE MR images were obtained at baseline and 1 year after treatment. In subjects with advanced lesions (>2 mm thick), MR image analysis was performed, including measurement of lipid-rich necrotic core size and kinetic modeling of DCE MR images to assess changes in the transfer constant (K(trans)). The differences in K(trans) between baseline and 1-year follow-up were compared by using the Wilcoxon signed rank test, and associations were assessed by using the Spearman rank correlation coefficient. RESULTS: Twenty-eight subjects with interpretable DCE MR imaging results at both baseline and 1-year follow-up were included. After 1 year of treatment, a significant reduction was found in mean K(trans) (0.085 min(-1) ± 0.037 [standard deviation] to 0.067 min(-1) ± 0.028, P = .02). Reduction in K(trans) was not significantly correlated with observed reductions in lipid-rich necrotic core size or reductions in HsCRP level. CONCLUSION: These findings suggest that DCE MR imaging may be a useful imaging method for the assessment of the therapeutic response of the vasa vasorum in patients with atherosclerotic plaque.
Authors: Arend F L Schinkel; Chris G Krueger; Armando Tellez; Juan F Granada; Jess D Reed; Anne Hall; William Zang; Cindy Owens; Greg L Kaluza; Daniel Staub; Blai Coll; Folkert J Ten Cate; Steven B Feinstein Journal: Eur J Echocardiogr Date: 2010-04-12
Authors: Diego Moguillansky; Xiaoping Leng; Andrew Carson; Linda Lavery; Abigail Schwartz; Xucai Chen; Flordeliza S Villanueva Journal: Eur Heart J Date: 2010-06-24 Impact factor: 29.983
Authors: J Herrmann; L O Lerman; M Rodriguez-Porcel; D R Holmes; D M Richardson; E L Ritman; A Lerman Journal: Cardiovasc Res Date: 2001-09 Impact factor: 10.787
Authors: Daniel Staub; Arend F L Schinkel; Blai Coll; Stefano Coli; Antonius F W van der Steen; Jess D Reed; Christian Krueger; Kai E Thomenius; Dan Adam; Eric J Sijbrands; Folkert J ten Cate; Steven B Feinstein Journal: JACC Cardiovasc Imaging Date: 2010-07
Authors: Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn Journal: N Engl J Med Date: 2008-11-09 Impact factor: 91.245
Authors: Tjun Y Tang; Simon P S Howarth; Sam R Miller; Martin J Graves; Andrew J Patterson; Jean-Marie U-King-Im; Zhi Y Li; Stewart R Walsh; Andrew P Brown; Peter J Kirkpatrick; Elizabeth A Warburton; Paul D Hayes; Kevin Varty; Jonathan R Boyle; Michael E Gaunt; Andrew Zalewski; Jonathan H Gillard Journal: J Am Coll Cardiol Date: 2009-06-02 Impact factor: 24.094
Authors: Sung Min Ko; Chao Zhang; Zhengjia Chen; Luis D'Marco; Antonio Bellasi; Arthur E Stillman; Geoffrey Block; Paolo Raggi Journal: J Nephrol Date: 2016-04-21 Impact factor: 3.902
Authors: Mark E Lobatto; Claudia Calcagno; Josbert M Metselaar; Gert Storm; Erik S G Stroes; Zahi A Fayad; Willem J M Mulder Journal: Methods Enzymol Date: 2012 Impact factor: 1.600